228 related articles for article (PubMed ID: 15950742)
61. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.
Rafati S; Zahedifard F; Azari MK; Taslimi Y; Taheri T
Exp Parasitol; 2008 Mar; 118(3):393-401. PubMed ID: 18093586
[TBL] [Abstract][Full Text] [Related]
62. Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice.
Gomes DC; Pinto EF; de Melo LD; Lima WP; Larraga V; Lopes UG; Rossi-Bergmann B
Vaccine; 2007 Mar; 25(12):2168-72. PubMed ID: 17240003
[TBL] [Abstract][Full Text] [Related]
63. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
Gamboa-León MR; Aranda-González I; Mut-Martín M; García-Miss MR; Dumonteil E
Scand J Immunol; 2007 Nov; 66(5):508-14. PubMed ID: 17953527
[TBL] [Abstract][Full Text] [Related]
64. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
[TBL] [Abstract][Full Text] [Related]
65. Vaccination of mice against intestinal Trichinella spiralis infections by oral administration of antigens microencapsulated in methacrilic acid copolymers.
Dea-Ayuela MA; Rama-Iñiguez S; Bolas-Fernández F
Vaccine; 2006 Apr; 24(15):2772-80. PubMed ID: 16446017
[TBL] [Abstract][Full Text] [Related]
66. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
[TBL] [Abstract][Full Text] [Related]
67. Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.
Fernandes AP; Herrera EC; Mayrink W; Gazzinelli RT; Liu WY; de Costa CA; Tavares CA; Melo MN; Michalick MS; Gentz R; Nascimento E
Rev Inst Med Trop Sao Paulo; 1997; 39(2):71-8. PubMed ID: 9394518
[TBL] [Abstract][Full Text] [Related]
68. IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs.
Oliveira TM; Mineo TW; Bason M; Day MJ; Machado RZ
Vet Parasitol; 2009 May; 162(1-2):16-22. PubMed ID: 19345019
[TBL] [Abstract][Full Text] [Related]
69. Leishmania infantum: mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice.
Rolão N; Cortes S; Gomes-Pereira S; Campino L
Exp Parasitol; 2007 Mar; 115(3):270-6. PubMed ID: 17087930
[TBL] [Abstract][Full Text] [Related]
70. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.
De Rossell RA; Bray RS; Alexander J
Parasite Immunol; 1987 Jan; 9(1):105-15. PubMed ID: 3562057
[TBL] [Abstract][Full Text] [Related]
71. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.
Debache K; Guionaud C; Alaeddine F; Mevissen M; Hemphill A
Int J Parasitol; 2008 Oct; 38(12):1455-63. PubMed ID: 18495126
[TBL] [Abstract][Full Text] [Related]
72. Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c mice.
Rafati S; Ghaemimanesh F; Zahedifard F
Vaccine; 2006 Apr; 24(16):3290-7. PubMed ID: 16481076
[TBL] [Abstract][Full Text] [Related]
73. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
Bhowmick S; Ravindran R; Ali N
Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
[TBL] [Abstract][Full Text] [Related]
74. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
[TBL] [Abstract][Full Text] [Related]
75. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
76. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
[TBL] [Abstract][Full Text] [Related]
77. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
78. Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 response.
Bryson K; Besteiro S; McGachy HA; Coombs GH; Mottram JC; Alexander J
Infect Immun; 2009 Jul; 77(7):2971-8. PubMed ID: 19433541
[TBL] [Abstract][Full Text] [Related]
79. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi].
Pérez HA; De la Rora M
Acta Cient Venez; 1986; 37(5):542-6. PubMed ID: 2966535
[No Abstract] [Full Text] [Related]
80. Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice.
Mazumder S; Ravindran R; Banerjee A; Ali N
Vaccine; 2007 Dec; 25(52):8771-81. PubMed ID: 18031874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]